Dexmedetomidine for heart protection after a specific heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 75 (including both ages).
- Have an anterior STEMI heart attack diagnosed within 6 hours of symptom onset.
- Your ECG must show ST elevation (≥0.2 mV) in 2+ nearby chest leads, including V2/V3/V4.
- Be able and willing to sign the informed consent form.
- Not have any major safety exclusions, such as severe shock, dangerous rhythm problems, or very low oxygen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a sedative called dexmedetomidine, along with your current care, can improve blood flow in small blood vessels under the tongue for people with septic shock in the ICU.
This study tests if a calming medicine given as a nasal spray before a heart stent procedure can prevent heart muscle damage. It's for people with coronary artery disease who are scheduled for a planned stent procedure.
This trial tests whether a drug called dexmedetomidine, given during general anesthesia, helps keep your heart rate and blood pressure stable during outpatient surgery. It may be an option if you are having a minor surgery and are not on certain heart medications.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
This trial tests whether a drug called dexmedetomidine can help prevent a common heart rhythm problem (atrial fibrillation) that can happen after mitral valve surgery. If you are having mitral valve surgery and are at risk for this arrhythmia, this could help you recover more smoothly.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.